ESC Premium Access

EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Session

About the speaker

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)
116 presentations
3 followers

4 more presentations in this session

EMPEROR-Preserved - Discussant review.

Speaker: Professor F. Ruschitzka (Zurich, CH)

Thumbnail

EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis

Speaker: Doctor M. Packer (Dallas, US)

Thumbnail

EMPEROR-Pooled - Discussant review.

Speaker: Professor R. De Boer (Groningen, NL)

Thumbnail

EMPEROR-Preserved / EMPEROR-Pooled - Panel discussion.

Thumbnail

Access the full session

Hot Line - EMPEROR-Preserved / EMPEROR-Pooled

Speakers: Professor S. Anker, Professor F. Ruschitzka, Doctor M. Packer, Professor R. De Boer
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACVC Premium Access

Proposed treatment after TTM2.

18 March 2022

ACVC Premium Access

TTM2: a game changer?

18 March 2022

ACVC Premium Access

Clinical trial evidence.

18 March 2022

This platform is supported by

logo Novo Nordisk